• The Effectiveness and Safety of Febuxostat - An Experience in Medical Center in Taiwan

    Nov 1, 2014, 00:00

  • Early Cost-Effectiveness Modeling for Tumor Infiltrating Lymphocytes (TIL) -Treatment Versus Ipilimumab in Metastatic Melanoma Patients

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Ranibizumab Versus Photodynamic Therapy for the Treatment of Neovascluar Age-Related Macular Degeneration Based in China Cost Setting

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania

    Nov 1, 2014, 00:00

  • Implementation of Technologies Based on the Evidence-Based Medicine and Hta in the Management of Hepatitis C

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Crizotinib Treatment In Alk+ Non-Small-Cell Lung Cancer Patients In Thailand

    Nov 1, 2014, 00:00

  • Survival Status in (Pharmaco) Epidemiological Studies can be Successfully Investigated Using Administrative Residential Registries

    Nov 1, 2014, 00:00

  • Market Analysis in Regard to Biologically Active Supplements And Medicines in Armenia

    Nov 1, 2014, 00:00

  • Hearing the Patient's Voice in Health Care- A Survey Analysis of Patients' Perceptions of Difficulties in Shared Clinical Decision-Making

    Nov 1, 2014, 00:00

  • The Cost Burden of Community-Acquired Pneumonia in Russia in Adults of 50 and Older- A Regional Study and National Estimates

    Nov 1, 2014, 00:00

  • Inpatient Case-Related Treatment Costs For Different Cardiovascular Diseases In Germany

    Nov 1, 2014, 00:00

  • Trends in Time To Market Access In Europe - Is It Getting Better?

    Nov 1, 2014, 00:00

  • Cognitive Function And Non-Adherence To Antihypertensive Medications

    Nov 1, 2014, 00:00

  • How do Organizational Arrangements of the Pharmaceutical Supply System Affect Availability to Essential Medicines in Rural China?

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in France

    Nov 1, 2014, 00:00

  • Choosing Important Health Outcomes For Comparative Effectiveness Research- A Systematic Review

    Nov 1, 2014, 00:00

  • Use Of External Data To Guide Long-Term Survival Extrapolations Of Trial Data For Chronic Lymphocytic Leukemia

    Nov 1, 2014, 00:00

  • The Burden Of Chronic Urticaria In Europe- A Systematic Literature Review

    Nov 1, 2014, 00:00

  • Impact of 2011 German Health Care Reform on Prices

    Nov 1, 2014, 00:00

  • The Long-Term Outcomes Of Bariatric Surgery On Patients With Type 2 Diabetes Mellitus- A Systematic Review And Meta-Analyses

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Panitumumab Plus Mfolfox6 Versus Bevacizumab Plus Mfolfox6 for First-Line Treatment of Patients with Wild-Type Ras Metastatic Colorectal Cancer

    Nov 1, 2014, 00:00

  • Value in the Making- Harvesting the Value of Complex Medical Innovations in Practice

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of High-Sensitive Troponin Assays For The Early Rule-Out Or Diagnosis Of Acute Myocardial Infarction (Ami) In People With Acute Chest Pain- A Nice Diagnostic Assessment

    Nov 1, 2014, 00:00

  • The Life and Death of the End of Life Treatment Appraisal Criteria in Nice Technology Appraisals?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Modeling Of Antimicrobial Dressings For Preventing Catheter-Related Bloodstream Infection- Homogeneous Verse Non-Homogeneous Markov Approaches

    Nov 1, 2014, 00:00

  • The Benefits and Challenges of Submitting to the Nice Medical Technologies Evaluation Programme-Manufacturer Perceptions And Experiences

    Nov 1, 2014, 00:00

  • What is the Status of Health Related Quality of Life Among Medical Representatives in India?

    Nov 1, 2014, 00:00

  • A Systematic Literature Review on Risk Factors for Cervical Cancer in Chinese Population

    Nov 1, 2014, 00:00

  • Uisess-B Oral Health Questionnaire Validity And Reliability In A Mexican Diabetic, Systemic Hypertension And Obese Patients

    Nov 1, 2014, 00:00

  • Can Using a Resource Use Log in an Economic Evaluation Alongside a Randomised Controlled Trial Reduce the Amount of Recall Bias?

    Nov 1, 2014, 00:00

  • The Cost Comparison Of Drug-Eluting Stents (Des) And Bare-Metal Stents (Bms) - A Retrospective Cohort Matched Study

    Nov 1, 2014, 00:00

  • Cost-Effectiveness and Long-Term Outcomes of Sovaldi (SOFOSBUVIR) for the Treatment of Chronic Hepatitis C Infected (HCV) Patients from a Swedish Societal Perspective

    Nov 1, 2014, 00:00

  • Meta-Analysis of Decision Impact and Net Decision Change in Adjuvant Chemotherapy Allocation in Early Stage Node-Negative, Estrogen Receptor-Positive Breast Cancer with a 21-Gene Assay

    Nov 1, 2014, 00:00

  • Methods for Health Economic Evaluations of Vaccines – Results from an International Expert-Workshop

    Nov 1, 2014, 00:00

  • Survey Findings on Evaluation of Traumatologist's Workload in Mongolia

    Nov 1, 2014, 00:00

  • Budget impact analysis of peritoneal dialysis versus. Conventional in-center hemodialysis in malaysia

    Nov 1, 2014, 00:00

  • A Systematic Review of Health State Utility Values for Advanced Ovarian Cancer

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Vismodegib Verse Standard of Care Therapy in the Treatment of Locally-Advanced or Symptomatic Metastatic Basal Cell Carcinoma in Hungary – A Global Cost-Effectiveness Model Adaptation

    Nov 1, 2014, 00:00

  • HTA Informed Price Negotiations- Cost Savings To The Health Payer in Ireland

    Nov 1, 2014, 00:00

  • Metformin in Combination With Dipeptidyl Peptidase-4 Inhibitors or Sulfonylureas in The Treatment of Type 2 Diabetes- Clinical And Economic Impact

    Nov 1, 2014, 00:00

  • Health Economic Models in Alzheimer's Disease- A Critical Assessment

    Nov 1, 2014, 00:00

  • Will Value Based Assessment (VBA) Revolutionise The Nice Assessment?

    Nov 1, 2014, 00:00

  • A Comparison of Factors Influencing Reimbursement and Coverage Decisions in Scotland (Smc), The Netherlands (Nzi) and Germany (G-Ba)

    Nov 1, 2014, 00:00

  • Modelling the Impact of Persistence Improvements with an Electronic Injection Device on Escalation to 2nd Line Treatment in Patients with Relapsing Remitting Multiple Sclerosis (RRMS)

    Nov 1, 2014, 00:00

  • Cost of Health Care Services Offered by Parkinson Disease Associations in Spain

    Nov 1, 2014, 00:00

  • Knowledge of HIV Status of Adolescents and Young Adults Attending an Adolescent HIV Clinic in Accra, Ghana

    Nov 1, 2014, 00:00

  • Development And Content Validity Testing Of A Treatment Acceptance Measure For Use In Hypercholesterolemia Patients Receiving Treatment Via Subcutaneous Injection

    Nov 1, 2014, 00:00

  • Likely Impact of Net Price Referencing on European Markets

    Nov 1, 2014, 00:00

  • Nuedexta for the Treatment of Pseudobulbar Affect- Estimating the Financial Impact to the Scottish NHS

    Nov 1, 2014, 00:00

  • Indirect Costs of Diabetes Mellitus (Dm) From the Perspective of The Social Insurance Institution (Zus) In Poland

    Nov 1, 2014, 00:00

  • Health State In Patients With Venous Thromboembolism On Conventional And Non-Vka Oral Anticoagulants As Assessed With The Eq-5d-5l Questionnaire- Prefer In Vte Registry

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Hydralazine and Magnesium Valproate LP Associated With Treatment for Adult Patients with Metastatic Recurrent or Persistent Cervical Cancer in Mexico

    Nov 1, 2014, 00:00

  • Non-Interventional Research Ethical Requirements in England and Fran Shared Experience From A Binational Research Project

    Nov 1, 2014, 00:00

  • The Comparison of the Risk-Sharing Schemes Proposed in Reimbursement Applications Received By Ahtapol In 2012 and 2013

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Threshold For Orphan Designations in Poland Based on Reimbursement Decisions

    Nov 1, 2014, 00:00

  • The Role Of Prior Breast Cancer Diagnosis In Articulating Expectations For Reconstructed Breast Appearance

    Nov 1, 2014, 00:00

  • The Oncology Pain Treatment Clinical Studies Quality Assessment

    Nov 1, 2014, 00:00

  • Modification of Patient Reported Outcomes Measures of Compliance, Gastrointestinal Symptoms, Palatability and Treatment Satisfaction for Patients Needing Iron Chelation therapy

    Nov 1, 2014, 00:00

  • The Use Of Minimally Invasive Surgery (Mis) And Intraoperative Imaging Modalities In The Treatment Of Intracerebral Hemorrhage (Ich)- A Systematic Review Of The Literature

    Nov 1, 2014, 00:00

  • Resource use and Costs for Managing HCV Genotype 1 Patients in Colombia from the Payers Perspective

    Nov 1, 2014, 00:00

  • A Cost-Analysis of Complex Radiotherapy in Patients with Head and Neck Cancer Results from the Art-Orl Study

    Nov 1, 2014, 00:00

  • An Indirect Treatment Comparison of Cabozantinib Verse Vandetanib in Progressive Medullary Thyroid Cancer (MTC)

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Assessment Of Apixaban Versus Standard Of Care For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients

    Nov 1, 2014, 00:00

  • Determination Of The Annual Health Insurance Cost Of Outpatient Care Physiotherapy Services For Low Back Pain

    Nov 1, 2014, 00:00

  • Histoculture Drug Response Assay in Colorectal Cancer

    Nov 1, 2014, 00:00

  • A Systematic Search and Methodological Review of Economic Models of Analgesics for Chronic Pain

    Nov 1, 2014, 00:00

  • Expert Elicitation Used for Early Technology Assessment to Inform on Cost-Effectiveness of Next Generation Sequencing

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of High-Dose Levofloxacin Therapy of Patients With Community-Acquired Pneumonia

    Nov 1, 2014, 00:00

  • In Vitro Drug Release and Ex Vivo Permeation Study of Prepared Mouth Dissolving Tablets of Fluconazole Through Porcine Buccal Mucosa

    Nov 1, 2014, 00:00

  • The Determinants of Uptake and Diffusion of Innovative Health Technologies. An Empirical Analysis

    Nov 1, 2014, 00:00

  • Why Are There Differences In Hta Recommendations Across Countries? A Systematic Comparison of Hta Decision Processes for A Sample of Orphan Drugs In Four Countries

    Nov 1, 2014, 00:00

  • Kazakhstan Verse Uzbekistan- A Review of the Drug Provision Systems

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Celecoxib and Non Selective Non Steroidal Anti-Inflammatory Drug (Nsaid) Therapy for the Treatment of Osteoarthritis in Spain- A Decision-Tree Model

    Nov 1, 2014, 00:00

  • Predictors of Working Motivation in Job Satisfaction Among Nurses in Cyprus

    Nov 1, 2014, 00:00

  • Pharmaceutical Developpement- Africa an Emergent Market

    Nov 1, 2014, 00:00

  • Dose-Response Network Meta-Analysis To Address Dose Heterogeneity In A Cost-Effectiveness Analysis In Acute Migraine

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Posaconazole Versus Fluconazole or Itraconazole in the Prophylaxis of Invasive Fungal Infections Among Neutropenic Patients in Thailand

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of a Shingles Vaccination Program to Prevent Herpes Zoster And Post- Herpetic Neuralgia in the Spanish Setting

    Nov 1, 2014, 00:00

  • Developing a Drug Price Reference Index in the Philippines

    Nov 1, 2014, 00:00

  • Cervical Human Papilloma Virus (HPV) DNA Primary Screening Test Results of the Experience of a Regional Laboratory in Central Italy

    Nov 1, 2014, 00:00

  • Survival After Locoregional Recurrence or Second Primary Breast Cancer- Impact of the Disease-Free Interval

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Lenalidomide-Plus-Dexamethasone in Multiple Myeloma Patients Who Have Received at Least One Prior Therapy- A South Korean Perspective

    Nov 1, 2014, 00:00

  • Recombinant Growth Hormone Therapy in Children with GH Deficiency- First Interventional Study in Armenia

    Nov 1, 2014, 00:00

  • Estimating Utility Data for Patient Symptom Severity in Chronic Spontaneous Urticaria

    Nov 1, 2014, 00:00

  • Impact of Morbidity in Populations of North London Clinical Commissioning Groups on Patient Admission Rates and Gp Referrals

    Nov 1, 2014, 00:00

  • Patient-Reported Outcomes of Dipeptidyl Peptidase-4 Inhibitors- A Systematic Review

    Nov 1, 2014, 00:00

  • Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infections (CDI) also Known as Clostridium Difficile-Associated Diarrhoea (CDAD) in Spain

    Nov 1, 2014, 00:00

  • Systematic Literature Review Assessing Data on the Burden of Allergic Rhinitis from a Cost and Quality of Life Perspective

    Nov 1, 2014, 00:00

  • Selection of Topics For Nice Technology Appraisal 2005-2011- What Matters Most?

    Nov 1, 2014, 00:00

  • Evaluating Rates of Potential Generic Substitution for Prescription Drugs- Can We Improve On Existing Incentive Schemes?

    Nov 1, 2014, 00:00

  • Cost of Best Supportive Care for Non-Small Cell Lung Cancer Patients – A German Perspective

    Nov 1, 2014, 00:00

  • Cost Of Illness- Heart Failure In Ireland

    Nov 1, 2014, 00:00

  • A Database Analysis Of Patients Eligible For Second-Line Lipid-Lowering Treatment For Hypercholesterolaemia In England

    Nov 1, 2014, 00:00

  • ESTIMATED ECONOMIC BURDEN OF INSULIN INJECTION-RELATED LIPOHYPERTROPHY IN CHINESE PATIENTS WITH DIABETES

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of the Therapy of Endometriosis

    Nov 1, 2014, 00:00

  • Incidence Of Unlicensed And Off-Label Prescription In Urologic Cancers Therapy In Turkey- Assessment Of Legislative And Regulatory Policy

    Nov 1, 2014, 00:00

  • Preventing the Progression to Type 2 Diabetes Mellitus in Adults at High Risk- A Systematic Review And Network Meta-Analysis of Lifestyle, Pharmacological and Surgical Interventions

    Nov 1, 2014, 00:00

  • Applying Multiple Criteria Decision Analysis in the Context of Health Technology Assessement- an Empirical Case Study

    Nov 1, 2014, 00:00

  • The Effectiveness of First Trimester Combined Screening on Reducing the Rate of Invasive Genetic Procedures in a City Based Population of Hungary 2010-2013

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Single-Pill Combination Therapy of Amlodipine/Atorvastatin Compared with Concurrent Two-Pill Therapy in Patients with Hypertension

    Nov 1, 2014, 00:00

  • Quality Of Life in Teenagers and Young Adolescent Patients With Diabetes Mellitus Type I With Insulin Pens Or Insulin Pumps In The Czech Republic

    Nov 1, 2014, 00:00

  • Economic Evaluetion of Fulvestrant 500 MG (F500) Versus Original Nonsteroidal Aromatase Inhibitors in Patient with Advanced Breast Canser in Russia (2 LINE THERAPY)

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Exenatide Bid Versus Insulin Lispro Tid As Add-On Therapy to Titrated Insulin Glargine in Patients With Type 2 Diabetes – An Analysis From The Swedish Health Care Perspective

    Nov 1, 2014, 00:00

  • Total Vaccine Cold Chain Volume Needed For Human Papillomavirus Vaccination In Bangladesh

    Nov 1, 2014, 00:00

  • Persistence in Open and Closed Data Sources- A Study of Fingolimod Verse Interferons/Glatiramer Acetate in Patients with Multiple Sclerosis

    Nov 1, 2014, 00:00

  • A Cost Comparison Analysis Of Medtronic's Stent Graft System To Competition For Endovascular Aneurysm Repair For Abdominal Aortic Aneurysms

    Nov 1, 2014, 00:00

  • Psychometric Evaluation of the Hypoglycaemia Perspectives Questionnaire in Patients With Type 2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • A Comparative Clinical Evaluation of Trayodashanga Guggulu and Mustadiyapana Yoga Basti in Gridhrasi

    Nov 1, 2014, 00:00

  • Belimumab for the Treatment of Systemic Lupus Erythematosus (Sle) In Gree A Cost-Effectiveness and Cost-Utility Analysis

    Nov 1, 2014, 00:00

  • Economic Implications Of Chronic Renal Disease With And Without Co-Morbid Diabetes In China, Post-2005

    Nov 1, 2014, 00:00

  • Multiple Decision Criteria for Assessing An Incremental Cost-Effectiveness Ratio of Expensive Health Technologies

    Nov 1, 2014, 00:00

  • Developing a Patient Centred Model for Clinicians to Individualise Cost Effective Treatment

    Nov 1, 2014, 00:00

  • Patterns of Asthma Treatment Utilization in Newly Diagnosed Elderly Patients are Inconsistent With Asthma Management Guidelines

    Nov 1, 2014, 00:00

  • A Potential Gender Bias in the Quality of Life - an Exploratory Standard Gamble Experiment Among Economics Students

    Nov 1, 2014, 00:00

  • Prevalence of Severe Treatment Resistant Hypertension and Eligibility for Catheter-Based Renal Denervation in Australia – a Preliminary Analysis

    Nov 1, 2014, 00:00

  • Comparison of Clinical Characteristics of Patients With Rheumatoid Arthritis (Ra) Receiving Biologic Monotherapy and Biologic-Containing Combination Therapy in Europe

    Nov 1, 2014, 00:00

  • Economic Evaluation of Bevacizumab Versus Ranibizumab in Neovascular Age-Related Macular Degeneration in China

    Nov 1, 2014, 00:00

  • Real World Incidences And Hospital Cost Of Venous And Pulmonary Thromboembolic Events In France

    Nov 1, 2014, 00:00

  • Frequency of Outpatient Physiotherapy Services in Neurology Diseases in Hungary

    Nov 1, 2014, 00:00

  • Trends and Key Decision Drivers For Rejecting An Orphan Drug Submission Across Five Different HTA Agencies

    Nov 1, 2014, 00:00

  • Effectiveness of Heavy-Light Chain Quantitative Test- A Systematic Review

    Nov 1, 2014, 00:00

  • An Analysis of Quality of Care in the Respiratory Care Center Based on Services Provided by Physicians with Different Responsibilities and Specialties

    Nov 1, 2014, 00:00

  • National Rare Disease Strategies- The Current State for Orphan Drug Market Access in European Union (Eu) Member States

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Empagliflozin (Jardiance®) 10 Mg And 25 Mg Administered As An Add-On To Metformin And Sulfonilurea (Met+Su) Compared To Other Sodium-Glucose Co-Transporter 2 Inhibitors (Sglt2is) in Patients with Type 2 Diabetes Mellit ...

    Nov 1, 2014, 00:00

  • An Ethic System Overview- Brazilian Perspectives For Observational Studies

    Nov 1, 2014, 00:00

  • Reimbursement Decisions in Oncology Drugs- An International Analysis

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Antiviral Therapy for Chronic Hepatitis B- A Systematic Review

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Dabigatran Compared With Warfarin, Apixaban, Rivaroxaban And Low Molecular Weight Heparins For The Treatment And Secondary Prevention Of Venous Thromboembolism In Colombia

    Nov 1, 2014, 00:00

  • Quality of Life in Patients With Axial Spondyloarthritis in Clinical Practice In Sweden- Baseline Results From A Longitudinal Study

    Nov 1, 2014, 00:00

  • Predictive Modelling- Predicting Hospitalisation And Estimating The Cost And Risk To The Third Party Funder

    Nov 1, 2014, 00:00

  • Avoiding and Identifying Errors and Other Threats To the Credibility of Health Economic Models

    Nov 1, 2014, 00:00

  • Applicability of Turkish Pricing Policy on Price Increases

    Nov 1, 2014, 00:00

  • Hospitalization Costs Associated With Liver Cirrhosis

    Nov 1, 2014, 00:00

  • Prevalence of Chronic Diseases Among Older Patients (>65 Years) in German General Practitioner Practices

    Nov 1, 2014, 00:00

  • Assessment of Medication Adherence in Rheumatoid Arthritis Patients in a Tertiary Care Hospital

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Introducing Biosimilar Infliximab for the Treatment of Auto Immune Disorders In Five European Countries

    Nov 1, 2014, 00:00

  • A Model to Estimate the Health System Burden of Prescription Opioid Abuse in Europe

    Nov 1, 2014, 00:00

  • A Budget Impact Analysis (Bia) Of The Use Of Paricalcitol For The Treatment Of Secondary Hyperparathyroidism (Shpt) In End Stage Renal Disease Patients

    Nov 1, 2014, 00:00

  • Medication Counseling Beyond Instituitional- Impact Of Pharmacist-Led Home Medication Review In Type 2 Diabetes Patients

    Nov 1, 2014, 00:00

  • Economic Evaluation Of Insulin Analogs Versus Human Insulin For Diabetes- A Systematic Review

    Nov 1, 2014, 00:00

  • Assessment Of The Huntington Quality Of Life Instrument (H-QOL-I) Cross-Cultural Validity

    Nov 1, 2014, 00:00

  • Estimating Overall Impact of Human Papillomavirus Vaccination on Cervical Cancer Burden in Spain and Portugal

    Nov 1, 2014, 00:00

  • Guidance for Risk Sharing Agreements / Pay Per- Results SCHEMES FOR PHARMACEUTICALS IN CATALONIA (SPAIN)

    Nov 1, 2014, 00:00

  • Questionnaire Analysis on Pharmacists Role and Drug Reimbursement List Adjustment Mechanism Under the Current China Health Insurance System

    Nov 1, 2014, 00:00

  • The Lumley-Method, A Recommended Network Meta-Analysis for Indirect Comparisons, Summarized for Practitioners

    Nov 1, 2014, 00:00

  • Guidance For Economic Evaluation and Budget Impact Analysis For Pharmaceuticals in Catalonia (Spain)

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Colonic Stents for the Management of Malignant Large Bowel Obstruction

    Nov 1, 2014, 00:00

  • Factors Associated with Relocating to Nursing Homes Among Community-Dwelling Older Persons with Dementia

    Nov 1, 2014, 00:00

  • Setting Targets For Public Spending Under Eu-Imf Assistance To Portugal - The Case Of Health Care and Pharmaceuticals

    Nov 1, 2014, 00:00

  • Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings from the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Knowledge of Human Papillomavirus among University Students in Hungary

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Fingolimod in Relapsing Remitting Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Drug Utilization Pattern for the Treatment of Septic Shock in the ICU- A Comparison Between Survivors and Non-Survivors in a Tertiary Care Teaching Institute

    Nov 1, 2014, 00:00

  • Understanding Caregiver Burden in Colorectal Cancer- What Role Do Patient And Carer Factors Play?

    Nov 1, 2014, 00:00

  • Economic Evaluation of Home Parenteral Nutriton in Cancer Patients; The French Context

    Nov 1, 2014, 00:00

  • Occurrence, Survival And Annual Cost of Colorectal-, Breast-, Prostate- and Lung Cancer in Hungary

    Nov 1, 2014, 00:00

  • Non-Steroidal Anti-Inflammatory Drugs in Household Drug Supplies in Serbia

    Nov 1, 2014, 00:00

  • A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases

    Nov 1, 2014, 00:00

  • Ldl-C Lowering Efficacy of Evolocumab (Amg 145) Could Reduce Apheresis in Patients At High Risk for Cardiovascular Events in Germany

    Nov 1, 2014, 00:00

  • Decision Drivers For Brazil- An Analysis of Conitec Recommendations

    Nov 1, 2014, 00:00

  • Racial Disparities in Type 2 Diabetes Health Care Utilization in Medicaid Adults With Developmental Disabilities

    Nov 1, 2014, 00:00

  • Ten Years Of Development Studies In Health Technology Assessment In Brazil- Profile Of Studies And Operational Indicators

    Nov 1, 2014, 00:00

  • Potentially Inappropriate Medication in the Elderly – Relevance and Economics of the 30 Top-Selling Priscus Agents in Germany

    Nov 1, 2014, 00:00

  • Implementation of A Collaborative Pharmacy Practice Model in Nursing Homes of A Swiss Canton- Drug Cost Monitoring Between 2009 and 2012

    Nov 1, 2014, 00:00

  • Predictors For Mortality Among Human Immunodeficiency Virus Infected Patients On Antiretroviral Therapy

    Nov 1, 2014, 00:00

  • Measuring and Observing Positive And Negative Externalities Caused By Vaccines- Do We Have The Right Assessment Approach Available?

    Nov 1, 2014, 00:00

  • UK Value-Based Assessment- Will Scotland's Smc Approach It In The Same Way?

    Nov 1, 2014, 00:00

  • Asthma Guideline Knowledge, Adherence and Cost of Treating Asthma at Emergency Department

    Nov 1, 2014, 00:00

  • A Kinematic Comparison of Overground and Treadmill Walking

    Nov 1, 2014, 00:00

  • Development And External Validation Of A Risk Calculator For Predicting Anemia In Patients Treated With Triple Therapy (Tt) Containing Boceprevir (Boc), Pegylated Interferon And Ribavirin (Pr)

    Nov 1, 2014, 00:00

  • Assesment Of Serial Transverse Enteroplasty- Systematic Review

    Nov 1, 2014, 00:00

  • CANCER TREATMENT IN CHINA- HOW ARE POLICY AND PRACTICE IN TIER 1 VERSUS TIER 2/3 CITIES IMPACTING PATIENT ACCESS TO HIGH-COST THERAPIES

    Nov 1, 2014, 00:00

  • Self-Reported Health Related Quality Of Life Of Hepatitis C Virus (Hcv) Genotype 1 Patients With And Without Comorbid Conditions

    Nov 1, 2014, 00:00

  • Functional Impairment and Cognitive Dysfunction in Depressed Patients in South-Korea- Results of Perform-K

    Nov 1, 2014, 00:00

  • Do Specialty Drugs Offer Greater Value for Money Than Traditional Drugs?

    Nov 1, 2014, 00:00

  • Economic Evaluation of Omalizumab Compared With Standard Therapy in the Treatment of Severe Allergic Asthma in Adult Patients in Gree a Cost Effectiveness Analysis Based on Clinical Trial and Real-World Data

    Nov 1, 2014, 00:00

  • Analysis of the Recent HTA Decision Making Landscape for Multiple Sclerosis Therapies – Trends and Future Opportunities

    Nov 1, 2014, 00:00

  • Risk of Bias in Trial-Based Economic Evaluations

    Nov 1, 2014, 00:00

  • Best Practices and Key Challenges in Cost-Effectiveness Modelling of Multiple Sclerosis Therapies

    Nov 1, 2014, 00:00

  • Outpatient Treatment of Adolescents with Antidepressants in Japan

    Nov 1, 2014, 00:00

  • Prescribing Patterns of General Practitioners (Gps) in Primary Health Care- Evidence From Greece

    Nov 1, 2014, 00:00

  • Work Productivity Improvement Associated With Apremilast, An Oral Phosphodiesterase 4 Inhibitor, in Patients With Psoriatic Arthritis Results Of A Phase 3, Randomized, Controlled Trial

    Nov 1, 2014, 00:00

  • Data Sources of Disease Epidemiology in German Drug Reimbursement Dossiers- Case Study Of Diabetes Mellitus Type II

    Nov 1, 2014, 00:00

  • Comparison of the Economic Burden and Health care Utilizations of u. S. Veteran Patients Diagnosed with Type 2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Drug Access Through Sharing Public And Individual Responsibilities In The Public Health Care System Of Singapore

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of 2-DOSE AS04-Adjuvanted Human Papillomavirus 16/18 Vaccination Schedule in Slovakia

    Nov 1, 2014, 00:00

  • Economic Burden of Pediatric Atopic Dermatitis in Asia-Pacific- A Review of the Literature

    Nov 1, 2014, 00:00

  • Knowledge and Perception of Medical and Pharmacy Students Toward The Usage of Sunblock

    Nov 1, 2014, 00:00

  • Systematic Review of Societal Cost of Illness Evidence in Patients With Psoriatic Arthritis

    Nov 1, 2014, 00:00

  • The Impact of the Income Per Capita in Chinese Family on Medical Expenditure

    Nov 1, 2014, 00:00

  • Results and implications of using a new eq-5d value set for cost-utility analyses in sweden. An application using enzalutamide (xtandi®) verse best supportive care for treatment of metastatic castration resistant prostate cancer (MCRPC)

    Nov 1, 2014, 00:00

  • Costs and Effectiveness of the Mediguide Technology in the Conditions of the Czech Republic

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Lithium Versus an Atypical Anti-Psychotic (AAP) used to Augment Treatment with a Selective Serotonin Reuptake Inhibitor (SSRI) in Treatment Resistant Depression (TRD)

    Nov 1, 2014, 00:00

  • Mapping May Cause Straining- The Inconsistent Relationship Between A Disease- Specific Questionnaire (Pac-Qol) And Eq-5d Mapping In Constipation

    Nov 1, 2014, 00:00

  • Comparative Efficacy and Safety of Empagliflozin with Other Anti-Diabetic Drugs for the Treatment of Patients with Type 2 Diabetes Mellitus Who are Failing Insulin

    Nov 1, 2014, 00:00

  • Measuring Change in Quality of Life- Can We Distinguish Recall Bias and Scale Recalibration?

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis Of Screening Strategies For Nonalcoholic Steatohepatitis

    Nov 1, 2014, 00:00

  • Patients' Acceptance of Their Medication- Results From a French Multi-Diseases Study With Patient Online Community Using the Acceptance By the Patients of Their Treatment (Accept©) Questionnaire

    Nov 1, 2014, 00:00

  • Comparison of a Markov Cohort Model and a Discrete-Event Simulation for Economic Analyses of Treatments for Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Trends In Early Engagement Between Industry And HTA- Analysis of Scientific Advice Service Provided By Nice Since 2009

    Nov 1, 2014, 00:00

  • The Effect of Procurement Design on Entry and Success of Generic Drug Firms

    Nov 1, 2014, 00:00

  • Analysis of Factors Causing Chronic Obstructive Pulmonary Disease in Eastern Region of China

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Biosimilar Infliximab For The Treatment Of Crohn's Disease In Six Central Eastern European Countries

    Nov 1, 2014, 00:00

  • Satisfaction of Hiv Patients with Pharmacy Services in South Eastern Nigerian Hospitals

    Nov 1, 2014, 00:00

  • Study of Medication Adherence in Diabetes Mellitus Patients with Hypertension

    Nov 1, 2014, 00:00

  • Bortezomib Re-treatment in Patients with Multiple Myeloma (MM). A Real World Medical Practice Experience from a Swedish National Registry

    Nov 1, 2014, 00:00

  • Benefit Of Positive Airway Pressure (Pap) Therapy In Sleep Apnoea (Sa) Patients With Type Ii Diabetes Mellitus (T2dm) In Germany- A Retrospective Comparative Cohort Analysis Based On A Statutory Health Insurance Database

    Nov 1, 2014, 00:00

  • Which Adverse Effects Influence the Dropout Rate in Selective Serotonin Reuptake Inhibitor (Ssri) Treatment?

    Nov 1, 2014, 00:00

  • Assessing The Relationship Between Individual Attributes Identified In Review Of Multi-Criteria Decision Analysis (MCDA) Of Rare Diseases And Annual Treatment Costs In Rare Endocrine Disorders

    Nov 1, 2014, 00:00

  • A Chart Abstraction Based Method to Classify Real World Patients With Pulmonary Arterial Hypertension Based on Who Functional Classification

    Nov 1, 2014, 00:00

  • Cost and Burden Of Hypercholesterolemia In Portugal

    Nov 1, 2014, 00:00

  • The Potential Societal Cost Benefits of Improved Inhalation Technique With Duoresp® Spiromax® (Budesonide + Formoterol Fumarate Dihydrate) Compared With Symbicort® Turbuhaler® for the Management of Asthma and Chronic Obstructive Pulmonary D ...

    Nov 1, 2014, 00:00

  • Qualitative Assessment of the Quality of Pharmaceutical Care Services in the Province of Khyber Pakhtunkhwa, Pakistan- Hospital Pharmacists' Views

    Nov 1, 2014, 00:00

  • Preferences Regarding The Attributes Of Oral Anticoagulants In Patients With Atrial Fibrillation Results Of A Discrete Choice Experiment

    Nov 1, 2014, 00:00

  • Antidepressant use and Suicide Rate in England- the Geographic Divide

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Theintroduction of A National Adherence Program for Type 2 Diabetes In Hungary

    Nov 1, 2014, 00:00

  • Demographics And Health Outcomes Associated With Adherence And Non-Adherence Among Type2 Diabetics In China

    Nov 1, 2014, 00:00

  • How Does Non-Malignant Opioid Induced Constipation (Oic) Impact Health State Utility?

    Nov 1, 2014, 00:00

  • Efficacy of Treatments for Macular Oedema Secondary to Branch Retinal Vein Occlusion- A Network Meta-Analysis

    Nov 1, 2014, 00:00

  • Incidence and Risk of Cardiotoxicity Induced by Sunitinib in Patients with Renal Cell Carcinoma- A Population-Based Case-Control Study in Chinese Population

    Nov 1, 2014, 00:00

  • The Impact Of Diabetes On Mortality In Inpatients From Medical Department Of A Chinese Tertiary Hospital

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Interventions Aimed at Decreasing The Number of Amputations Among Patients With Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Aripiprazole Once-Monthly is a Cost-Effective Therapeutic Option in the Maintenance Treatment of Schizophrenia- Results from a Markov Model

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation

    Nov 1, 2014, 00:00

  • Premixed Insulin Lispro Versus Insulin Glargine In Type 2 Diabetes- A Meta-Analysis

    Nov 1, 2014, 00:00

  • Product Quality Aspect in Reimbursement of Medical Devices- Comparison of Turkey Verse Europe

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis Of An Antimicrobial Transparent Dressing For Protecting Central Vascular Accesses In Critically Ill Patients Versus Standard Transparent Dressings In Fran A Comparison Of Two Modeling Approaches- Decision-Tree Ve ...

    Nov 1, 2014, 00:00

  • Joint Modelling Of The Change In Tumor Size And Overall Survival; A Parametric Model Considering Patient Heterogeneity Not Observed At Baseline

    Nov 1, 2014, 00:00

  • German Patients' Preferences for Attributes Of Type 2 Diabetes Medications

    Nov 1, 2014, 00:00

  • A Prospective, Cross-Sectional Study On Cost And Adherence Of Antidiabetic Prescriptions At A Tertiary Care Teaching Hospital In South India

    Nov 1, 2014, 00:00

  • Change in Percentage of Left Ventricular Ejection Fraction in Breast Cancer Patients Received Trastuzumab Treatment

    Nov 1, 2014, 00:00

  • Drug Survival Rates And Cost of Biological Agents for the Treatment of Moderate to Severe Psoriasis in the Balearic Islands (Spain)

    Nov 1, 2014, 00:00

  • A DE-NOVO Model to Predict Outcomes of a New Hypothetical Intervention to Reduce CV Risk in Post Mi Patients

    Nov 1, 2014, 00:00

  • The Development and Preliminary Validation of the Manchester Early Morning Symptoms Index (Memsi) for People With Chronic Obstructive Pulmonary Disease (Copd)

    Nov 1, 2014, 00:00

  • Economic Evaluation of Nalmefene for the Treatment of Alcohol Dependence in Greece

    Nov 1, 2014, 00:00

  • Clinical Trial-Based Cost-Effectiveness Analysis of Indacaterol (ONBREZ® 150 MCG) Versus Tiotropium (SPIRIVA®) in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) IN TURKEY

    Nov 1, 2014, 00:00

  • Boosting Biosimilars Uptake in European Countries

    Nov 1, 2014, 00:00

  • An Italian Oncology Research to Evaluate Adherence to Clinical Guidelines for Cancer Treatment- The Right Program

    Nov 1, 2014, 00:00

  • Long Term Survival of Patients with Various Lung Cancer Histology in Seer Between 2004-2011

    Nov 1, 2014, 00:00

  • Top 20 Orphan Drugs Availability, Pricing and Reimbursement In Slovakia- 2005-2012 Review

    Nov 1, 2014, 00:00

  • Impact of Health Policy Changes on the Growth Locally Manufactured and Imported Pharmaceutical Markets In Turkey

    Nov 1, 2014, 00:00

  • Patient Preferences- Pro Mixed Modes – Epro Versus Paper

    Nov 1, 2014, 00:00

  • Coverage Decision Framework in Asia Pacific- A Case Study of Targeted Cancer Medicines in the Treatment of Breast Cancer

    Nov 1, 2014, 00:00

  • Opioid Prescribing and the Impact of Branded Generics

    Nov 1, 2014, 00:00

  • A Cost Effectivness Analysis of Everolimus Compared with Axitinib in the Treatment of Metastatic Renal Cell Carcinoma in the United Kingdom

    Nov 1, 2014, 00:00

  • Study On Drug Utilization And Assessment Of Stroke Risk Using Chads2 And Cha2ds2-Vasc Scoring In Elderly Patients With Non-Valvular Atrial Fibrillation

    Nov 1, 2014, 00:00

  • Systematic Review of Economic Evaluations in Cancerology In Brazil Between 1980 And 2013

    Nov 1, 2014, 00:00

  • Modelling Long-Term Changes In Opioid Induced Constipation (OIC)

    Nov 1, 2014, 00:00

  • Dose Titration, Persistence, and Adherence to Statin Therapy Among Patients with High-Risk Vascular Disease in Japan

    Nov 1, 2014, 00:00

  • Quality of Life in Hospitalized Seniors with Psychiatric Disorders

    Nov 1, 2014, 00:00

  • Impact of Caregiving for Patients with Alzheimer's Disease and Dementia on Psychiatric and Clinical Comorbidities in Brazil

    Nov 1, 2014, 00:00

  • The Relevance of Health Services Research for the Pharmaceutical Industry in Germany –Results of A Representative Online Survey

    Nov 1, 2014, 00:00

  • Comparison of Methods to Estimate Health State Utilities in Metastatic Breast Cancer (MBC)

    Nov 1, 2014, 00:00

  • Adjusting for Treatment Crossover in A Trametinib Metastatic Melanoma Rct- Identifying the Appropriate Method

    Nov 1, 2014, 00:00

  • Simulation of An Additional Go/No-Go Efficacy Interim Analysis in A Head-To-Head Rct

    Nov 1, 2014, 00:00

  • Evaluating Relationship Between White Blood Cells and Platelets During Recovery Phase In Dengue Hemorrhagic Fever Cases In Punjab, Pakistan- A Retrospective Study

    Nov 1, 2014, 00:00

  • Quality of Life in Patients with Multiple Myeloma in Slovakia

    Nov 1, 2014, 00:00

  • Awarness and Prevention of Chronic Diseases in Japan

    Nov 1, 2014, 00:00

  • A Database Study to Investigate the Incidence of Anaphylaxis and the Prescription Rate of Self-Injection Epinephrine in Japan

    Nov 1, 2014, 00:00

  • Hipos-ER (Hypoglycemia in Portugal Observational Study – Emergency Room)- Outcomes with Different Anti-Hyperglycemic Agents

    Nov 1, 2014, 00:00

  • Estimating The Costs Of Specialist Out-Patient Services In A Public Hospital

    Nov 1, 2014, 00:00

  • Health Related Quality of Life And Health Care Utilization in Primary Care Patients With Moderate/Persistent Severity Asthma

    Nov 1, 2014, 00:00

  • Qaly Weightings Based on the Burden of Illness Applied to a Uk Cost-Effectiveness Analysis of Nab-Paclitaxel + Gemcitabine Versus Gemcitabine Alone for the Treatment of Metastatic Pancreatic Cancer

    Nov 1, 2014, 00:00

  • Transitional Clinic Utilization and General Well Being of Ugandan Young Adults Living with HIV/AIDS

    Nov 1, 2014, 00:00

  • Cost of Severe Hypoglycaemia in Hospitalized Patients In Poland- Is It Financed and Reported in a Right Way?

    Nov 1, 2014, 00:00

  • Determinants of Health Care Utilization in Hypertensive Patients- A Longitudinal Analysis

    Nov 1, 2014, 00:00

  • Evaluation of The Impact of Pharmaceutical Cognitive Service on Quality of Life in Diabetic Patients

    Nov 1, 2014, 00:00

  • Discrepancy Between National Drug Recommendations And Local Uptake in the Swedish Inpatient Sector

    Nov 1, 2014, 00:00

  • A Systematic Review of Cost-Effectiveness Analysis of Cd4 Cell Count Verse Hiv Viral Load in Primarily Resource-Limited Setting

    Nov 1, 2014, 00:00

  • Are Patient Reported Outcomes Relevant To Patients? Learnings From A Patient Advocate Survey

    Nov 1, 2014, 00:00

  • When It May Not Be Necessary To Model Overall Survival for Economic Evaluations of Anti-Cancer Drugs

    Nov 1, 2014, 00:00

  • The Impact Of Daytime And Nocturnal Non-Severe Hypoglycaemic Events On People With Diabetes In Turkey

    Nov 1, 2014, 00:00

  • Evaluation of the Economic Burden of Menopausal Women in the U. S. Medicaid Program

    Nov 1, 2014, 00:00

  • Economic Burden in Direct Costs of Chronic Obstructive Pulmonary Disease (COPD) in Russia

    Nov 1, 2014, 00:00

  • Long-Term Work Productivity Costs Among Subjects With Early Rheumatoid Arthritis - A Nationwide Analysis Based on 7,831 Subjects' Sickness Absence Days and Income

    Nov 1, 2014, 00:00

  • Quality of Diabetes Care Among Obese and Overweight Patients at Nhg Polyclinics

    Nov 1, 2014, 00:00

  • Disutility Associated With Erectile Dysfunction in the Middle-Aged Or Older Males

    Nov 1, 2014, 00:00

  • Romiplostim Cost Per Response In Itp Treatment In the Brazilian Health Care System

    Nov 1, 2014, 00:00

  • Trends In Clinical Drug Development Timeframes, 1981-2013 – An Example From Virology

    Nov 1, 2014, 00:00

  • Analyses on Temporal and Spatial Clustering and Changing Trend of HCV in Mainland of China

    Nov 1, 2014, 00:00

  • Integration of Cost–Effectiveness Assessment in the Market Access Scheme of Drugs and Medical Devices In France

    Nov 1, 2014, 00:00

  • Evaluating The Gap Between Physicians' And Patients' Understanding Of Patient Needs

    Nov 1, 2014, 00:00

  • An Analysis of the 2014 Moroccan Drug Price Cuts

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Ustekinumab Compared With Etanercept for the Treatment of Moderate to Severe Psoriasis in Costa Rica

    Nov 1, 2014, 00:00

  • Health Related Quality of Life Among Young Smokers

    Nov 1, 2014, 00:00

  • Annual Cost Of Conservative Treatment Of Supraventricular Tachycardias In Poland

    Nov 1, 2014, 00:00

  • Work Productivity Loss Due To Rheumatoid Arthtiris (Ra), Crohn's Disease (Cd) And Psoriasis (Ps) In Poland

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of A Short Message Service (Sms) Intervention To Prevent Type 2 Diabetes Among Adults With Impaired Glucose Tolerance

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Different Scenarios of Detecting of TB Among HIV-Infected People Depending on CD 4+ Count

    Nov 1, 2014, 00:00

  • Cic Users' Preference For Catheters Reducing The Uti Frequency

    Nov 1, 2014, 00:00

  • In-Patient Hospital Costs of Stroke- A Focused Literature Review

    Nov 1, 2014, 00:00

  • Impact of Economic Crisis on the Greek Health Care System and on the Population Health

    Nov 1, 2014, 00:00

  • Microsimulation Model For The Assessment Of Personalized Cancer Care- The Mapcca Model Framework

    Nov 1, 2014, 00:00

  • The Effect of Degressive Financing Method on the Hungarian Drg Based Hospital Reimbursement Between 2011-2013

    Nov 1, 2014, 00:00

  • Economic Impact of Using Subcutaneous Trastuzumab

    Nov 1, 2014, 00:00

  • Drug Access Is Improved By The Essential Drug System And “Low-Priced Drug” Policy In China

    Nov 1, 2014, 00:00

  • Regulatory Issues in Pro Advertising- A Review of the Ddmac/Opdp Letters From 1998 To 2013 To Identify Pro Claims Violations and Examine Their Evolution Over Time

    Nov 1, 2014, 00:00

  • Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilisation Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy

    Nov 1, 2014, 00:00

  • Payer's Perceptions of Glucagon Kits Aimed at Reducing Administration Complexity During Severe Hypoglycemic Events

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Analysis of Two Pegylated Interferon ALFA Treatment for Chronic HCV Infection in China

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Dolutegravir Compared to Raltegravir in Treatment Naive and Treatment Experienced Patients in Slovak Settings

    Nov 1, 2014, 00:00

  • Characteristics of Patients With Systemic Lupus Erythematosus (Sle) Currently On Remission, With Active Disease But Not Experiencing Flare, and Those Experiencing Flares In Clinical Practices In Europe

    Nov 1, 2014, 00:00

  • Resource Use and Health Care Costs of Chronic Obstructive Pulmonary Disease in Slovakia

    Nov 1, 2014, 00:00

  • Assesing the Impact of Patent Loss on Overall Revenues and Stocks Price of Pharmaceutical Companies

    Nov 1, 2014, 00:00

  • Health Care use and Oral Medication Patterns for Type 2 Diabetes Patiets in China：The Role of Traditional Chinese Medicines

    Nov 1, 2014, 00:00

  • Pricing Additional Benefit in Germany

    Nov 1, 2014, 00:00

  • Modelling Longitudinal Trajectories of Patient-Reported Outcomes To Evaluate Treatment Effect

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of the Treatment of Respiratory Diseases of Xiyanping Injection - A Systematic Review

    Nov 1, 2014, 00:00

  • Comparative Effectiveness Research of Medical Devices – New Methods Needed?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia In Portugal

    Nov 1, 2014, 00:00

  • Systematic Review of Observational Studies and Rcts of Omalizumab in Severe Persistent Allergic Asthma and Meta-Analysis Feasibility Assessment

    Nov 1, 2014, 00:00

  • Validity of the Eq-5d-5l in Stroke Patients

    Nov 1, 2014, 00:00

  • Awareness of Hyperlipidemia Among University Students and Staff Member

    Nov 1, 2014, 00:00

  • Comparison of Disease Status And Outcomes of Patients With Rheumatoid Arthritis (Ra) Receiving Adalimumab or Etanercept Monotherapy In Europe

    Nov 1, 2014, 00:00

  • Fidaxomicin Therapy for Patients with Clostridium Difficile Infection- A Systematic Literature Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • What is the Most Cost-Effective Strategy for Treating Chronic Myeloid Leukemia After Imatinib Loses Patent Exclusivity in Europe?

    Nov 1, 2014, 00:00

  • The Medical Costs of Chronic Obstructive Pulmonary Disease in South Korea

    Nov 1, 2014, 00:00

  • Development Of A Collaborative European Pharmacoepidemiologic Post-Authorization Safety Study (Pass) Programme Examining Rivaroxaban Use In Routine Clinical Practice

    Nov 1, 2014, 00:00

  • Calculating Indirect Costs – Differences Caused by Various Approaches to Unit Costs. Results of Move to Work Study (M2W)

    Nov 1, 2014, 00:00

  • Should Cost-Effectiveness Analysis Include The Cost Of Consumption Activities? An Empirical Investigation

    Nov 1, 2014, 00:00

  • The Cost of Blindness in the Republic of Ireland 2010-2020

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Study of Botulinium Toxin Type a in Treatment of Post-Stroke Spasticity in the Russian Federation- Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Joint Modeling of Primary and Secondary Non-Adherence Outcomes

    Nov 1, 2014, 00:00

  • The Selection of Appropriate Health State Utility Values (Hsuvs) for Health Technology Assessment (Hta)- Lessons To Be Learnt

    Nov 1, 2014, 00:00

  • The Research of Effects of Iguratimod(T-614) on the Apoptosis of Peripheral Blood Mononuclear Cell and TH1 in Rheumatoid Arthritis

    Nov 1, 2014, 00:00

  • Study on Clinical and Immunological Outcomes of Antiretroviral Therapy in Hiv Positive Adult Patients in a Community Care Hospital

    Nov 1, 2014, 00:00

  • Assessment of the Methodological Quality of Randomized Controlled Trials Published in "Russian Allergology Journal" in 2009-2013

    Nov 1, 2014, 00:00

  • Initial Inappropriate Antibiotic Therapy in Hospitalized Patients with Gram-Negative Infections- Systematic Review And Meta-Analysis

    Nov 1, 2014, 00:00

  • Economic Modeling of The Use of Botulinum Toxin A in A Homogenous Patient Population Based on Real-Life Clinical Practi Ulis-Ii (The Upper Limb International Spasticity Study)

    Nov 1, 2014, 00:00

  • Retrospective Chart Review Studies- Strategies To Ensure Robust Data Quality

    Nov 1, 2014, 00:00

  • Economic Evaluation Of Ferric Carboxymaltose In Patients With Chronic Heart Failure And Iron Deficiency- An Analysis For Greece Based On Fair-Hf Trial

    Nov 1, 2014, 00:00

  • Nice's Proposed Value-Based Assessment of Health Technologies- Concerns of Inconsistent Consideration of Social Values

    Nov 1, 2014, 00:00

  • The Pan-Genotypic Costs-Effectiveness Of Sofosbuvir in Hepatitis C Virus

    Nov 1, 2014, 00:00

  • Patient Envolvement in Reimbursment of Drugs in Slovakia

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Guangdong Rural Tertiary Breast Cancer Screening and Diagnosis System

    Nov 1, 2014, 00:00

  • Ten Years Outcomes in a Cohort of Patients Started on Antiretroviral Treatment in an Urban Clinic in Sub-Saharan Africa

    Nov 1, 2014, 00:00

  • Effectiveness of Hand Hygiene Promotion in Relation to Level of Investment- A Systematic Review

    Nov 1, 2014, 00:00

  • Everolimus Plus Exemestane Compared to Exemestane and Fulvestrant for the Treatment of ER+ HER2- Metastastic Breast Cancer in the United Kingdom – A Societal Perspective

    Nov 1, 2014, 00:00

  • Comparing Three Different Methods of Half-Cycle Correction

    Nov 1, 2014, 00:00

  • Clinical Outcome Assessment (Coa) Instrument Scoring- the Validity and Precision of Unweighted Summary Scores Verse Irt Weighted Scores, and the Added Value of Irt Standard Errors

    Nov 1, 2014, 00:00

  • Economic Evaluation of Lanreotide Autogel in the Management of Acromegaly in Greece

    Nov 1, 2014, 00:00

  • Coping with methicillin resistant staphylococcus aureus (MRSA) in german rehabilitation centers – are the incentives appropriate?

    Nov 1, 2014, 00:00

  • Adding Boceprevir Yields Better Cost-Saving for Chronic Hepatitis C Genotype 1 Treatment in Thailand

    Nov 1, 2014, 00:00

  • Clinical and Economic Analysis of Effectiveness of Everolimus in the Treatment Of HR+, HER2- Advanced Breast Cancer in Russia

    Nov 1, 2014, 00:00

  • Management of Ischaemic Stroke Patients Enrolled in the Japan Stroke Databank (JSD)

    Nov 1, 2014, 00:00

  • Assessing the Comparative Outcomes from Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms- Use of “Number Needed to Treat” Analysis

    Nov 1, 2014, 00:00

  • Modeling Disease Progression In Alzheimer's Dementia To Inform HTA (CEA)

    Nov 1, 2014, 00:00

  • WX-III-287-19 A Possible Thromboxane Antagonist in Bovine Coronary Arteries

    Nov 1, 2014, 00:00

  • Budget Impact of Orphan Drugs In the Netherlands In The Period 2006-2012

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Ipilimumab for Previously Untreated Patients with Advanced Metastatic Melanoma in Spain

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Bendamustin-Rituximab Compared to Chop-Rituximab in the Treatment of Indolent Follicular Non-Hodgkin Lymhoma in the Czech Republic

    Nov 1, 2014, 00:00

  • Patient-Reported Fall Related Health Care Services in Elderly Women

    Nov 1, 2014, 00:00

  • Shared Decision-Making in Women with Early Stage Breast Cancer and Implications for Long-Term Health-Related Quality of Life

    Nov 1, 2014, 00:00

  • The Health Economic Impact of Resource use in Dementia- the Erlanger Dementia Registry (EDR)

    Nov 1, 2014, 00:00

  • Saving Money in Health Care- Cost Effectiveness of Individual Drugs (As By Nice) Or Budget Cuts (As Under Pprs)?

    Nov 1, 2014, 00:00

  • Launching Novel Class Iii Implantable Cardiac Devices for Cardiology in Europe First, Is This Common Commercial Practice Improving Health Care Quality for Europeans

    Nov 1, 2014, 00:00

  • Pay-For-Performan Balancing Cost and Care

    Nov 1, 2014, 00:00

  • Cost of Pharmacotherapy in Polish Patients With Rheumatoid Arthritis

    Nov 1, 2014, 00:00

  • Collaborative Approach in Accessing Homogeneous Medical Data in Grid-Based Environment (Enhancing Diseases Classification)

    Nov 1, 2014, 00:00

  • Whatever Happened To Nice Value-Based Pricing? Welcome, Value-Based Assessment

    Nov 1, 2014, 00:00

  • Patient Preferences in Treatment of Diabetes Mellitus- A Systematic Review of Stated Preference Surveys

    Nov 1, 2014, 00:00

  • Evidences and Criteria Related to the Hospital Service Quality and Safety

    Nov 1, 2014, 00:00

  • Pharmacy Cost Calculator for Hepatitis C Virus Patients in Turkey

    Nov 1, 2014, 00:00

  • The Incidence Of Upper And Lower Gastrointestinal Complications- A Retrospective Study Using A Japanese Health Care Database

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Ranibizumab on Patients With Diffuse Diabetic Macular Edema Within the Public Mexican Health Care System

    Nov 1, 2014, 00:00

  • Cost Effectiveness of Pentavalent Rotavirus Vaccine (Rv5) in Slovenia

    Nov 1, 2014, 00:00

  • Clinical Trials in Fran An Underexploited Opportunity

    Nov 1, 2014, 00:00

  • Influenza Vaccination In Japan Among The General Population And High-Risk Groups

    Nov 1, 2014, 00:00

  • Resources Utilization for the Investigation of Pulmonary Nodules in a University Hospital Center in Quebec, Canada

    Nov 1, 2014, 00:00

  • Median Hospitalization Cost and Length of Stay for Carbapenem-Resistant Verse Carbapenem-Sensitive Patients in a Tertiary Care Hospital in South India

    Nov 1, 2014, 00:00

  • Availability of Risk Sharing Agreements in the Turkish Pharmaceutical Sector

    Nov 1, 2014, 00:00

  • Progression of Physiological Parameters Over Time in Type 1 Diabetes Mellitus Patients in France

    Nov 1, 2014, 00:00

  • Quality of Life Decrements after Stroke

    Nov 1, 2014, 00:00

  • The Inverse Correlation Between Internal And External Risk Under International Reference Pricing- An Analysis of Six European Countries

    Nov 1, 2014, 00:00

  • Comparative Cost-Effectiveness of CT Perfusion for Selecting Stroke Patients for Thrombolysis

    Nov 1, 2014, 00:00

  • Components of Sustainable Health Systems- What Is Known About The Cost-Effectiveness of Clinical Care?

    Nov 1, 2014, 00:00

  • Assessment Of Diabetes Knowledge In Healthy Population Of Quetta City, Pakistan

    Nov 1, 2014, 00:00

  • Efficacy Of Novel Dmards In Early Active Rheumatoid Arthritis- An Indirect Comparison

    Nov 1, 2014, 00:00

  • The Importance and Use of Drug Utilization Review and Pharmacoeconomics

    Nov 1, 2014, 00:00

  • The Impact of Drug Policy on the Utilization of Medicines for Treatment of Cardiovascular Diseases in Slovak Republic

    Nov 1, 2014, 00:00

  • Using the Analytic Hierarchy Process To Derive Health State Utilities From Ordinal Preference Data

    Nov 1, 2014, 00:00

  • The Pain Assessment for Lower Back Symptoms (Pal-S)- Refinement of A New Pro Instrument Through A Mixed Methods Approach

    Nov 1, 2014, 00:00

  • A Critical Review of Chinese Pharmacoeconomics Studies in the Last Five Years

    Nov 1, 2014, 00:00

  • Knowledge on Medication Taking Behaviour, Balanced Diet and Physical Activity - A Survey Among the Adolescents

    Nov 1, 2014, 00:00

  • Market Access and Reimbursement- The Increasing Role of Real-World Evidence

    Nov 1, 2014, 00:00

  • Health Care Stakeholders' Evaluation of A User-Friendly Tool Which Estimates Long-Term Health Gains Following the Reduction of Ldl Levels

    Nov 1, 2014, 00:00

  • Valuing EQ-5D-5L- Does the Ordering of the Health Dimensions Impact on Health State Valuations?

    Nov 1, 2014, 00:00

  • Management of Crises and Risks in German Hospitals - Factors Influencing Medication Errors

    Nov 1, 2014, 00:00

  • Economic Burden of Major Depressive Disorder (Mdd) in Five European Countries- Description of Resource use by Health State

    Nov 1, 2014, 00:00

  • Cost Comparison Among First Line Monoclonal Antibodies-Based Oncology Treatment Protocols

    Nov 1, 2014, 00:00

  • Assessing Assessment- Does Health Technology Assessment Do Its Job of Controlling Costs Without Compromising Quality?

    Nov 1, 2014, 00:00

  • Current Management and Barriers to Treatment for Wet Age-Related Macular Degeneration (Wamd)- Perspectives From Patients and Caregivers

    Nov 1, 2014, 00:00

  • The Importance of Long-Term Surveillance of Stage IB Melanomas- Unexpectedly Low Survival Subsequent to Recurrence

    Nov 1, 2014, 00:00

  • Hta Studies On Orphan Drugs By Rebratsxmembers

    Nov 1, 2014, 00:00

  • A Comparison of Patient-Reported and Laboratory Outcomes Between Hemodialysis and Peritoneal Dialysis Patients in a Multi-Ethnic Asian Population

    Nov 1, 2014, 00:00

  • Cost-Benefit-Analysis of a Targeted Hospital Wide Pcr-Based Admission Screening for Mrsa in a German University Hospital – Consideration of a Six-Year Time Period

    Nov 1, 2014, 00:00

  • What are the Key Driving Factors Behind RSA Decisions In Australia?

    Nov 1, 2014, 00:00

  • From Regulatory Approval to Subsidised Patient Access in the Asia-Pacific Region- A Comparison of Systems Across Australia, China, Japan, Korea, New Zealand, Taiwan And Thailand

    Nov 1, 2014, 00:00

  • A Comaprative Cross-Sectional Study On Health-Related Quality Of Life In Psoriasis From Hungary And Iran

    Nov 1, 2014, 00:00
  • «
  • 101
  • 102 (current)
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • »